Trademark Overview
On Monday, August 11, 2025, a trademark application was filed for REYAROS with the United States Patent and Trademark Office. The USPTO has given the REYAROS trademark a serial number of 99331143. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 19, 2025. This trademark is owned by Juno Therapeutics, Inc.. The REYAROS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer;; Pharmaceutical preparations for the treatment and prevention of Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; preparations for medical purposes.
